Matthew Walsh
Director of Finance/CFO at ORGANON & CO.
Net worth: 5 M $ as of 31/03/2024
Profile
Matthew M. Walsh holds the position of Chief Financial Officer for Organon & Co. and Director & Vice President at Topokine Therapeutics, Inc. He is also on the board of Certara USA, Inc. and Certara, Inc. Mr. Walsh previously was President, Chief Executive & Financial Officer at Spectrum Group International, Inc., CFO, Treasurer & Controller at GenTek, Inc., Chief Financial Officer & Executive Vice President of Catalent, Inc. and Chief Financial Officer & Executive Vice President of Catalent Pharma Solutions, Inc. (a subsidiary of Catalent, Inc.), Chief Financial Officer & Executive Vice President of Allergan Ltd. (Ireland) and Chief Financial Officer, Director & Executive VP at Allergan GI Corp. Matthew M. Walsh received an undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERTARA, INC.
0.11% | 23/05/2023 | 176,968 ( 0.11% ) | 3 M $ | 31/03/2024 |
ORGANON & CO.
0.03% | 31/03/2024 | 84,109 ( 0.03% ) | 2 M $ | 31/03/2024 |
Matthew Walsh active positions
| Companies | Position | Start |
|---|---|---|
| CERTARA, INC. | Director/Board Member | 01/08/2017 |
| ORGANON & CO. | Director of Finance/CFO | 02/06/2021 |
Topokine Therapeutics, Inc.
 Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Director/Board Member | - |
Certara USA, Inc.
 Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Director/Board Member | 26/08/2020 |
Certara Holdings, Inc.
 Certara Holdings, Inc. Packaged SoftwareTechnology Services Part of Certara, Inc., Certara Holdings, Inc. develops software for clinical pharmacology. The private company is based in Princeton, NJ. William F. Feehery has been the CEO of the company since 2019. | Director/Board Member | - |
Former positions of Matthew Walsh
| Companies | Position | End |
|---|---|---|
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Director of Finance/CFO | 01/06/2020 |
| ALLERGAN PLC | Director of Finance/CFO | 08/05/2020 |
| ALLERGAN, INC. | Director of Finance/CFO | 01/01/2020 |
| CATALENT, INC. | Director of Finance/CFO | 01/01/2018 |
| ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Matthew Walsh
| Cornell University | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| SPECTRUM GROUP INTERNATIONAL, INC. | Retail Trade |
| CATALENT, INC. | Health Technology |
| CERTARA, INC. | Technology Services |
| ORGANON & CO. | Health Technology |
| Private companies | 9 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Multi-Color Corp.
 Multi-Color Corp. Commercial Printing/FormsCommercial Services Multi-Color Corp. engages in the provision of label solutions supporting. Its products include pressure sensitive labels, in-mold labels, heat transfer labels, glue-applied labels, shrink sleeve labels, and graphic services. The company was founded in 1916 and is headquartered in Batavia, OH. | Commercial Services |
GenTek, Inc.
 GenTek, Inc. Chemicals: SpecialtyProcess Industries GenTek, Inc. manufactures industrial components and performance chemicals. It offers ground and flight instrumentation, complete environmental testing, industrial and process control, satellite tracking and control, and aircraft structural testing. The company was founded in 1994 and is headquartered in Tampa, FL. | Process Industries |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Topokine Therapeutics, Inc.
Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Health Technology |
Certara Holdings, Inc.
Certara Holdings, Inc. Packaged SoftwareTechnology Services Part of Certara, Inc., Certara Holdings, Inc. develops software for clinical pharmacology. The private company is based in Princeton, NJ. William F. Feehery has been the CEO of the company since 2019. | Technology Services |
- Stock Market
- Insiders
- Matthew Walsh
